SCHEMBL5344711

SCHEMBL5344711

COc1ccc(CNC(=O)[C@H](CSCC2CCCCC2)NC(=O)OC(C)(C)C)cc1OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.47
PKM P14618 1/20 0.47
RAB9A P51151 1/20 0.47
CTSD P07339 3/20 0.46
CACNA1B Q00975 4/20 0.45
REN P00797 5/20 0.45
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
PSMB1 P20618 2/20 0.42
PSMB8 P28062 2/20 0.42
PSMB9 P28065 2/20 0.42
PSMB5 P28074 2/20 0.42
PSMB10 P40306 1/20 0.42
PSMB2 P49721 1/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
TSHR P16473 2/20 0.42
CYP2C19 P33261 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5117016 0.90 CACNA1B (0.43) CTSDCACNA1BRENCYP3A4
SCHEMBL5349086 0.87 PSMB1 (0.51) CACNA1BRENPPARGPPARAPSMB1
SCHEMBL5348084 0.85 CACNA1B (0.60) NPC1PKMRAB9ACTSDCACNA1B
SCHEMBL5344714 0.84 NPC1 (0.49) NPC1PKMRAB9ACTSDCACNA1B
SCHEMBL5351453 0.83 CACNA1B (0.47) NPC1PKMRAB9ACTSDCACNA1B
Hydrochloric Acid SCHEMBL5351726 0.82 CACNA1B (0.47) NPC1PKMRAB9ACTSDCACNA1B
SCHEMBL5361976 0.82 CACNA1B (0.57) NPC1RAB9ACACNA1BRENPPARG
SCHEMBL5348792 0.82 CACNA1B (0.57) NPC1RAB9ACACNA1BRENPPARG
SCHEMBL5124533 0.82 CTSS (0.49) CACNA1BRENPPARGPPARACYP3A4
SCHEMBL4846817 0.81 CACNA1B (0.59) CACNA1BRENPPARGPPARACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0997147-B1 AMINO ACID DERIVATIVES ONO PHARMACEUTICAL CO (JP) 2006-03-15 EP claimed
US-20030013725-A1 Amino acid derivatives ONO PHARMACEUTICAL CO., LTD. 2003-01-16 US claimed
EP-0997147-A1 AMINO ACID DERIVATIVES Ono Pharmaceutical Co., Ltd. (JP) 2000-05-03 EP claimed
US-7166590-B2 Amino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2007-01-23 US disclosed
US-7166590-B2 Amino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2007-01-23 US disclosed
EP-0997147-B1 AMINO ACID DERIVATIVES ONO PHARMACEUTICAL CO (JP) 2006-03-15 EP disclosed
US-20030013725-A1 Amino acid derivatives ONO PHARMACEUTICAL CO., LTD. 2003-01-16 US disclosed
EP-0997147-A1 AMINO ACID DERIVATIVES Ono Pharmaceutical Co., Ltd. (JP) 2000-05-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013725-A1 Amino acid derivatives CACNA1B, SCN1A, SCN2A NPC1 534/4885PKM 3859/4885RAB9A 2425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.